# Critical Doping for the Onset of Fermi-Surface Reconstruction by Charge-Density-Wave Order in the Cuprate Superconductor La$ _{2-x} $Sr$_{x} $CuO$ _{4}$

Preprint · S. Badoux, S. A. A. Afshar, B. Michon, A. Ouellet, S. Fortier, D. LeBoeuf, T. P. Croft, C. Lester, S. M. Hayden, H. Takagi, K. Yamada, D. Graf, N. Doiron-Leyraud, Louis Taillefer

- Archive id: arxiv:1512.00292
- Published: 2015-12-01
- Venue: Phys. Rev. X 6, 021004 (2016)
- DOI: https://doi.org/10.1103/physrevx.6.021004
- arXiv: https://arxiv.org/abs/1512.00292
- Source URL: https://arxiv.org/abs/1512.00292
- PDF: https://arxiv.org/pdf/1512.00292
- Provenance: arxiv

## Abstract

The Seebeck coefficient $S$ of the cuprate superconductor La$ \_{2-x} $Sr$\_{x} $CuO$ \_{4}$ (LSCO) was measured in magnetic fields large enough to access the normal state at low temperatures, for a range of Sr concentrations from $x = 0.07$ to $x = 0.15$. For $x = 0.11$, 0.12, 0.125 and 0.13, $S/T$ decreases upon cooling to become negative at low temperatures. The same behavior is observed in the Hall coefficient $R\_{H}(T)$. In analogy with other hole-doped cuprates at similar hole concentrations $p$, the negative $S$ and $R\_{H}$ show that the Fermi surface of LSCO undergoes a reconstruction caused by the onset of charge-density-wave modulations. Such modulations have indeed been detected in LSCO by X-ray diffraction in precisely the same doping range. Our data show that in LSCO this Fermi-surface reconstruction is confined to $0.085 \< p \< 0.15$. We argue that in the field-induced normal state of LSCO, charge-density-wave order ends at a critical doping $p\_{\\rm CDW} = 0.15 \\pm 0.005$, well below the pseudogap critical doping $p^\\star \\simeq 0.19$.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.